Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omegawave is a digital health and sports performance technology company focused on non-invasive physiological readiness assessment for athletes, coaches, tactical professionals, physiotherapists, and sports medicine users. Its system combines central nervous system measurements using DC-EEG with cardiac measurements using heart rate variability to help users assess recovery status and optimize daily training decisions. The company markets hardware-plus-software products including Omegawave Coach/Coach+ for teams and practitioners and Omegawave Personal for individual athletes. Omegawave was founded in 1999, operated from Espoo, Finland, and was acquired by OTO on October 26, 2022. Following the acquisition, the Omegawave brand and products have remained active as part of OTO's broader human performance and health technology portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omegawave.